Adjuvant Aspirin: Big Benefits for Some CRC PatientsAdjuvant Aspirin: Big Benefits for Some CRC Patients

Dr. David Kerr reports on a study providing more evidence that patients with PIK3CA-mutant colorectal cancer benefit most from adjuvant aspirin therapy, but awaits prospective trials for confirmation. Medscape Oncology
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Hematology-Oncology Commentary Source Type: news